CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating activities:
Net income attributable to common shareholders	$ 171.8	$ 122.8	$ 228.9
Noncontrolling interest in subsidiaries' earnings	0.7	1.0	1.1
Net income before allocation to noncontrolling interests	172.5	123.8	230.0
Asbestos provision	0.0	192.4	0.0
Gain on deconsolidation of joint venture	(1.0)	0.0	0.0
Gain on sale of property related to facility consolidation	(11.1)	0.0	0.0
Restructuring - Non Cash	0.0	0.0	2.0
Depreciation and amortization	72.7	67.4	67.0
Stock-based compensation expense	21.8	21.7	21.3
Defined benefit plans and postretirement credit	(8.5)	(9.1)	(11.6)
Deferred income taxes	102.3	(25.1)	39.7
Cash provided by (used for) operating working capital	54.0	27.0	(16.1)
Defined benefit plans and postretirement contributions	(13.2)	(8.8)	(17.9)
Environmental payments, net of reimbursements	(6.3)	(11.6)	(18.2)
Payments for asbestos-related fees and costs, net of insurance recoveries	(62.5)	(56.0)	(49.9)
Other	3.2	3.6	17.0
Total provided by operating activities	317.5	318.1	229.3
Investing activities:
Capital expenditures	(49.0)	(51.5)	(39.6)
Proceeds from disposition of capital assets	22.3	0.9	4.4
Impact of deconsolidation of joint ventures	(5.2)	0.0	0.0
Payments for acquisitions, net of cash acquired	(54.8)	0.0	0.0
Total used for investing activities	(86.7)	(50.6)	(35.2)
Financing activities:
Dividends paid	(78.4)	(77.2)	(76.6)
Reacquisition of shares on open market	(25.0)	0.0	(25.0)
Stock options exercised - net of shares reacquired	25.2	26.4	8.9
Excess tax benefit from stock-based compensation	0.0	0.0	0.1
Proceeds received from issuance of long-term notes	0.0	0.0	(100.0)
(Repayments) proceeds from issuance of commercial paper - net	0.0	(49.6)	48.8
Debt issuance costs	2.6	0.0	0.0
Total used for financing activities	(80.8)	(100.4)	(143.8)
Effect of exchange rates on cash and cash equivalents	46.5	(20.9)	(33.1)
Increase in cash and cash equivalents	196.5	146.2	17.2
Cash and cash equivalents at beginning of period	509.7	363.5	346.3
Cash and cash equivalents at end of period	706.2	509.7	363.5
Detail of cash used for working capital:
Accounts receivable	(10.1)	(6.2)	(2.4)
Inventories	6.4	24.9	(23.0)
Other current assets	0.8	(2.4)	(3.0)
Accounts payable	17.5	5.5	3.3
Accrued liabilities	30.8	9.6	6.1
U.S. and foreign taxes on income	8.6	(4.4)	2.9
Total	54.0	27.0	(16.1)
Supplemental disclosure of cash flow information:
Interest paid	36.0	36.8	37.5
Income taxes paid	$ 84.1	$ 69.8	$ 51.1